Berry launches child-resistant PET bottles for pharma as flu remedy demand grows
15 Feb 2023 --- Berry Global Healthcare is introducing a new PET bottle combination for the pharmaceutical syrup and herbal market for liquid medicines. The bundle aims to help customers capitalize on the increasing demand for child-resistant and tamper-evident packaging.
Customers can select the bottle and compatible closure with liners and dosing cups to meet their particular application and capacity requirements. To help companies meet their sustainability objectives, some bottles can be produced in 100% food-grade recycled PET.
Berry explains its new bundle features seven ranges of 28 mm neck PET bottles in sizes from 20 mL to 1,000 mL.
The package combination is supplied from eight Berry factories across Europe, ensuring a fast and flexible service for companies of all sizes to help them quickly bring products to market.
The company says it is utilizing its longstanding design and technical expertise in the healthcare sector to combine a range of bottle and closure solutions that can meet the market’s diverse needs.
Some of the bottles and closures are fully tested and certified as child-resistant to the latest global standards – ISO8317 standard (EU) and 16CFR1700.20 standard (US). Berry asserts these measures ensure that the packaging is safe and meets regulatory requirements.
PET for healthcare
The certification covers the EPE42A, EPE Saranex, F217-4 (PE Faced EPE) and I.H.S liners. These certifications apply to bottles with 50 mL to 250 mL capacity.
Berry explains that PET bottles are the perfect packaging solution for healthcare products because the strong and lightweight material makes them break-resistant, convenient, safe and easy to handle during transportation and for the end-user.
Furthermore, PET bottles provide an effective barrier against oxygen and moisture ingress, protecting the efficacy of the medicines. The bottles allow products to be clearly viewed and easily labeled and branded.
Healthcare bundle launch
Berry says the new bundle has been developed in light of increasing demand for pharmaceutical plastic bottles, caps and closures for the OTC sector, which offer an attractive alternative to glass packaging. Furthermore, the company is also seeing particular interest in solutions for coughs, colds and flu remedies, such as syrups and decongestants.
The Berry Healthcare bundle was launched at the recent Pharmapack exhibition in Paris, France, February 1-2.
“We had a very positive reaction from visitors to our stand,” comments Nadine Khoury, senior strategic marketing manager, Berry Healthcare. “In particular, the extensive choice of bottles and closures was very appealing as it enables us to provide individual customers with the best option to meet their needs.”
“This also demonstrates our commitment to being a trusted supplier and preferential partner to the industry.”
Earlier this month, Berry Global Group also announced it is setting up a new manufacturing facility and healthcare center in India’s “Silicon Valley,” Bangalore (officially Bengaluru), to improve global access to healthcare products, leveraging the company’s R&D solutions. Production at the site is expected to begin in the next two months.
“The aim [of the Greenfield expansion project] is to support Asia’s growing demand for healthcare products with a range of high-quality, patient-centric packaging and devices. The new site will be located close to some of the largest generic pharmaceutical companies,” a Berry spokesperson shared with PackagingInsights.
Edited by Natalie Schwertheim
To contact our editorial team please email us at firstname.lastname@example.org
Subscribe now to receive the latest news directly into your inbox.